World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26050
World Ranking
13248
National Ranking
6748

Overview

David G. McLeod was affiliated with the Uniformed Services University of the Health Sciences in the United States. Their research primarily focused on medical and biomedical fields, particularly within medicine, engineering, and biochemistry, genetics, and molecular biology.

The subfields of McLeod's work included pulmonary and respiratory medicine, biomedical engineering, molecular biology, cardiology and cardiovascular medicine, and cancer research.

Main research topics addressed through their work were:

  • Prostate cancer treatment and research
  • Prostate cancer diagnosis and treatment
  • Microfluidic and capillary electrophoresis applications
  • Innovative microfluidic and catalytic techniques innovation
  • Cardiac electrophysiology and arrhythmias
  • 3D printing in biomedical research
  • Cancer, lipids, and metabolism

Some of their frequent coauthors included Shiv Srivastava, Zhenyu Li, Albert Dobi, Inger L. Rosner, and Isabell A. Sesterhenn, with collaboration counts ranging from six to nine works.

David G. McLeod published multiple research articles in various scientific journals, notably in bioRxiv (Cold Spring Harbor Laboratory), Scientific Reports, Cancer Epidemiology Biomarkers & Prevention, Cancer, and Prostate Cancer and Prostatic Diseases.

Notable papers authored or coauthored by McLeod included:

  • "Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry," 2020, published in Prostate Cancer and Prostatic Diseases
  • "Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer," 2020, published in Journal of Translational Medicine
  • "Prognostic features of Annexin A2 expression in prostate cancer," 2020, published in Pathology
  • "Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression," 2022, published in Scientific Reports
  • "Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia," 2021, published in Scientific Reports

Best Publications

  • A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

    E D Crawford;M A Eisenberger;D G McLeod;J T Spaulding

  • Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

    Mario A. Eisenberger;Brent A. Blumenstein;E. David Crawford;Gary Miller

  • Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men

    Ted O. Morgan;Steven J. Jacobsen;William F. McCarthy;Debra J. Jacobson

  • Frequent Detection of Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancers

    Jaya P. Gaddipati;David G. McLeod;Howard B. Heidenberg;Isabell A. Sesterhenn

  • Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT–Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens

    Jun Miki;Bungo Furusato;Hongzhen Li;Yongpeng Gu

  • Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

    Christopher L. Amling;Robert H. Riffenburgh;Leon Sun;Judd W. Moul

  • Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

    Gyorgy Petrovics;Aijun Liu;Syed Shaheduzzaman;Bungo Furasato

  • NEOADJUVANT ANDROGEN ABLATION BEFORE RADICAL PROSTATECTOMY IN cT2bNxMo PROSTATE CANCER: 5-YEAR RESULTS

    Mark S. Soloway;Kapil Pareek;Rooholiah Sharifi;Zev Wajsman

  • PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

    Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu

  • Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.

    David G. Mcleod;Peter Iversen;William A. See;Thomas Morris

  • Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy

    Jason C. Massengill;Leon Sun;Judd W. Moul;Hongyu Wu

  • Prostate-Specific Antigen Values at the Time of Prostate Cancer Diagnosis in African-American Men

    Judd W. Moul;Isabell A. Sesterhenn;Roger R. Connelly;Thomas Douglas

  • Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.

    Judd W. Moul;Judd W. Moul;Hongyu Wu;Leon Sun;David G. McLEOD

  • Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

    John J. Bauer;Isabell A. Sesterhenn;F.K. Mostofi;David G. McLeod

  • Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program

    William A. See;Manfred P. Wirth;David G. McLeod;Peter Iversen

  • TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation.

    C. Sun;A. Dobi;A. Mohamed;H. Li

  • MULTICENTER PATIENT SELF-REPORTING QUESTIONNAIRE ON IMPOTENCE, INCONTINENCE AND STRICTURE AFTER RADICAL PROSTATECTOMY

    Tzu-Cheg Kao;David F. Cruess;Daniel Garner;John Foley

  • BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS

    Manfred P. Wirth;William A. See;David G. McLEOD;Peter Iversen

  • ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

    Furusato B;Tan Sh;Young D;Dobi A

  • PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.

    Linda L. Xu;Bennett G. Stackhouse;Kim Florence;Wei Zhang

Frequent Co-Authors

Shiv Srivastava
Shiv Srivastava Uniformed Services University of the Health Sciences
Judd W. Moul
Judd W. Moul Duke University
Isabell A. Sesterhenn
Isabell A. Sesterhenn United States Army Research Laboratory
Anthony V. D'Amico
Anthony V. D'Amico Brigham and Women's Hospital
Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Mario A. Eisenberger
Mario A. Eisenberger Johns Hopkins University
Oliver Sartor
Oliver Sartor Tulane University
E. David Crawford
E. David Crawford University of California, San Diego
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Matthew L. Freedman
Matthew L. Freedman Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online medical and healthcare degrees can open new doors for those interested in medicine but seeking different paths. For instance, direct msn programs online are a fast-track option for non-nurses looking to advance quickly in the nursing profession. These programs allow individuals with a non-nursing background to obtain a Master of Science in Nursing through an accelerated, flexible format.

Prospective nursing students concerned about admission barriers might consider researching what is the easiest nursing school to get into. This list highlights schools with less competitive entry requirements, making the transition into nursing more accessible.

Beyond clinical practice, allied health degrees like medical billing and coding schools that accept financial aid provide entry into essential behind-the-scenes roles. These accredited programs offer important financial support options for students.

Finally, if standardized tests are a concern, you may want to apply to nursing schools that don't require teas or HESI exams. These schools focus on alternative admission criteria, potentially simplifying your journey toward a nursing career.

Best Scientists Citing David G. McLeod